Annual Total Expenses
$167.36 M
+$15.73 M+10.37%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual total expenses is $167.36 million, with the most recent change of +$15.73 million (+10.37%) on December 31, 2023.
- During the last 3 years, RPTX annual total expenses has risen by +$112.92 million (+207.43%).
- RPTX annual total expenses is now at all-time high.
Performance
RPTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$34.84 M
-$3.55 M-9.24%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly total expenses is $34.84 million, with the most recent change of -$3.55 million (-9.24%) on September 30, 2024.
- Over the past year, RPTX quarterly total expenses has dropped by -$5.73 million (-14.13%).
- RPTX quarterly total expenses is now -20.65% below its all-time high of $43.91 million, reached on December 31, 2023.
Performance
RPTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RPTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | -14.1% |
| 3 y3 years | +207.4% | +9.0% |
| 5 y5 years | +1205.4% | +407.4% |
RPTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.0% | -20.6% | at low |
| 5 y | 5-year | at high | +534.5% | -20.6% | +293.9% |
| alltime | all time | at high | +2610.2% | -20.6% | +629.1% |
Repare Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.84 M(-9.2%) |
| Jun 2024 | - | $38.39 M(-7.7%) |
| Mar 2024 | - | $41.59 M(-5.3%) |
| Dec 2023 | $167.36 M(+10.4%) | $43.91 M(+8.2%) |
| Sep 2023 | - | $40.58 M(-4.5%) |
| Jun 2023 | - | $42.51 M(+5.3%) |
| Mar 2023 | - | $40.36 M(+6.7%) |
| Dec 2022 | $151.63 M(+30.4%) | $37.83 M(-3.4%) |
| Sep 2022 | - | $39.15 M(-0.7%) |
| Jun 2022 | - | $39.41 M(+11.9%) |
| Mar 2022 | - | $35.24 M(-1.1%) |
| Dec 2021 | $116.26 M | $35.61 M(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $31.96 M(+18.6%) |
| Jun 2021 | - | $26.95 M(+23.9%) |
| Mar 2021 | - | $21.75 M(+26.3%) |
| Dec 2020 | $54.44 M(+106.4%) | $17.21 M(+22.2%) |
| Sep 2020 | - | $14.09 M(+14.3%) |
| Jun 2020 | - | $12.32 M(+13.9%) |
| Mar 2020 | - | $10.81 M(+22.3%) |
| Dec 2019 | $26.38 M(+105.7%) | $8.85 M(+28.8%) |
| Sep 2019 | - | $6.87 M(+16.7%) |
| Jun 2019 | - | $5.88 M(+23.1%) |
| Mar 2019 | - | $4.78 M |
| Dec 2018 | $12.82 M(+107.6%) | - |
| Dec 2017 | $6.17 M | - |
FAQ
- What is Repare Therapeutics annual total expenses?
- What is the all time high annual total expenses for Repare Therapeutics?
- What is Repare Therapeutics annual total expenses year-on-year change?
- What is Repare Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Repare Therapeutics?
- What is Repare Therapeutics quarterly total expenses year-on-year change?
What is Repare Therapeutics annual total expenses?
The current annual total expenses of RPTX is $167.36 M
What is the all time high annual total expenses for Repare Therapeutics?
Repare Therapeutics all-time high annual total expenses is $167.36 M
What is Repare Therapeutics annual total expenses year-on-year change?
Over the past year, RPTX annual total expenses has changed by +$15.73 M (+10.37%)
What is Repare Therapeutics quarterly total expenses?
The current quarterly total expenses of RPTX is $34.84 M
What is the all time high quarterly total expenses for Repare Therapeutics?
Repare Therapeutics all-time high quarterly total expenses is $43.91 M
What is Repare Therapeutics quarterly total expenses year-on-year change?
Over the past year, RPTX quarterly total expenses has changed by -$5.73 M (-14.13%)